Shares of Vyant Bio, Inc. (OTCMKTS:VYNT – Get Free Report) were up 7.8% during mid-day trading on Thursday . The company traded as high as $0.20 and last traded at $0.19. Approximately 19,100 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 161,822 shares. The stock had previously closed at $0.18.
Vyant Bio Price Performance
The company has a debt-to-equity ratio of 0.04, a current ratio of 2.86 and a quick ratio of 2.86. The firm has a 50 day moving average price of $0.19 and a 200-day moving average price of $0.19.
Vyant Bio Company Profile
Vyant Bio, Inc, a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD).
Featured Stories
- Five stocks we like better than Vyant Bio
- About the Markup Calculator
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- Compound Interest and Why It Matters When Investing
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for Vyant Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vyant Bio and related companies with MarketBeat.com's FREE daily email newsletter.
